B. REFERENCES RELEVANT TO CANCER TREATMENTS
Site addresses are not allowed in the blog, so they are deleted.
ACS Early Theories about Cancer Causes, American Cancer Society. accessed at ...*cancer*cancer-basics*history-of-cancer*cancer-causes-theories-throughout-history.file
Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7:834–846.
Albero A, Lopéz JE, Torres A, de la Cruz L, Martín T. Effectiveness of chemotherapy in advanced differentiated thyroid cancer: a systematic review. Endocr Relat Cancer. 2016 Feb;23(2):R71-84. doi: 10.1530*ERC-15-0194.
Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer. 1954;8(1):1–12.
Armitage P, Doll R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer. 1957;11(2):161–9.
Ashdown ML, Robinson AP, Yatomi-Clarke SL, Ashdown ML, Allison A, Abbott D, Markovic SN, and Coventry BJ, Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates, Version 1. F1000Res. 2015; 4:232.
Attolini CS, Michor F. Evolutionary Theory of Cancer. The Year in Evolutionary Biology 2009: Ann. N.Y. Acad. Sci. 1168: 23–51 (2009).
Au DH, Castro M, and Krishnan JA. Selection of Controls in Clinical Trials, Introduction and Conference Summary. Proceedings of The American Thoracic Society Vol 4 2007
Bai ZG, Zhang ZT. A systematic review and meta-analysis on the effect of angiogenesis blockade for the treatment of gastric cancer. Onco Targets Ther. 2018 Oct 17;11:7077-7087.
Bailon-Moscoso N, Cevallos-Solorzano G, Romero-Benavides JC, and Orellana MIR. Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies. Current Genomics, 2017, 18, 106-131
Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012;2:1143–1211.
Brigden ML. Unproven (questionable) cancer therapies. West J Med. 1995 Nov; 163(5): 463–469.
Brücher B, Jamall IS. Somatic Mutation Theory - Why it’s Wrong for Most Cancers. Cell Physiol Biochem 2016;38:1663-1680
Carlsson S, Andersson T, Lichtenstein P, Michaelsson K, Ahlbom A. Physical activity and mortality: is the association explained by genetic selection? Am J Epidemiol. 2007; 166:255–259.
Chang SC, Liu KH, Hung CY et al. Adjuvant Chemotherapy Improves Survival in Stage III Gastric Cancer after D2 Surgery. Journal of Cancer 2018; 9(1): 81-91.
Chen CP, Weinberg VK, Jahan TM, Jablons DM, and Yom SS. Implications of Delayed Initiation of Radiotherapy Accelerated Repopulation after Induction Chemotherapy for Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology Volume 6, Number 11, November 2011.
Cheng L, Swartz MD, Zhao H, Kapadia AS, Lai D, Rowan PJ, Buchholz TA, Giordano SH. Hazard of recurrence among women after primary breast cancer treatment—A 10-year follow-up using data from SEER-medicare. Cancer Epidemiol. Biomarkers Prev. 21, 800–809 (2012).
Colleoni M, Sun Z, Price KN, Karlsson, Forbes JF, Thürlimann B, Gianni L, Castiglione M, Gelber RD, Coates AS, Goldhirsch A. Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to V. J. Clin. Oncol. 34, 927–935 (2016).
Cormie P, Zopf EM, Zhang X, Schmitz KH. The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects. Epidemiologic Reviews, Volume 39, Issue 1, January 2017, Pages 71–92
Davis C, Naci H, Gurpinar E, Poplavska E, Pinto A, Aggarwal A, Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13, BMJ 2017;359:j4530.
Demicheli R, Retsky MW, W. Hrushesky JM, Baum M. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: Learning from failures. Nat. Clin. Pract. Oncol. 2007; 4,699–710.
DeVita VT Jr, Chu E. A history of cancer chemotherapy. Cancer Res. 2008 Nov 1;68(21):8643-53.
Des Guetz G, Uzzan B, Bouillet T, et al. Impact of physical activity on cancer-specific and overall survival of patients with colorectal cancer. Gastroenterol Res Pract. 2013;2013: 340851.
Donaldson MS. Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutr J. 2004; 3: 19.
Dos Santos MA, Pignon JP, Blanchard P, Lefeuvre D, Levy A, Touat M, Louvel G, Dhermain F, Soria JC, Deutsch E, Le Teuff G. Systematic review and meta-analysis of phase I*II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival. J Neurooncol. 2015 Jun;123(2):307-14. doi: 10.1007*s11060-015-1802-5.
Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Feuer E, de Koning H. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. Journal of the National Cancer Institute. 2009; 101:374–83.
Drewinko B, Alexanian R, Boyer H, Barlogie B, Rubinow SI. The growth fraction of human myeloma cells. Blood. 1981 Feb;57(2):333-8.
Friedenreich CM, Neilson HK, Farris MS, et al. Physical activity and cancer outcomes: a precision medicine approach. Clin Cancer Res. 2016;22(19):4766–4775.
Gee AW, Balogh E, Patlak M, Nass SJ (reportors), The Drug Development Paradigm in Oncology: Proceedings of a Workshop. National Academies of Sciences; National Cancer Policy Forum. Washington (DC): National Academies Press (US); 2017 Jul 24.
Gimbrone MA, Jr, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med. 1972;136(2):261–276.
Greaves M, Maley CC. Clonal evolution in cancer. Nature. 2012;481(7381):306–13.
Grosso G, Bella F, Godos J, Sciacca S, Del Rio D, Ray S, Galvano F, Giovannucci EL. Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nutrition Reviews, 2017; 75 (6):405–419.
Hanahan & Weinberg. The Hallmarks of Cancer. Cell, Vol. 100, 57–70, January 7, 2000.
Harv Letter. A second look at beta blockers and blood pressure. A beta blocker alone isn't usually the best choice for simple, uncomplicated high blood pressure. Harv Heart Lett. 2008 Jun;18(10):4-5.
Holmes MD, Chen WY, Feskanich D, et al. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293(20):2479–2486.
Hochberg, ME & Noble RJ. A framework for how environment contributes to cancer risk. Ecology Letters (2017) 20, 117–134.
Hoffman KE, Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, et al. Physician Variation in Management of Low-Risk Prostate Cancer: A Population-Based Cohort Study. JAMA Intern Med. 2014
Housman G., Byler S., Heerboth S.h, Lapinska K, Longacre M., Snyder N. and Sarkar S., Drug Resistance in Cancer: An Overview. Cancers 2014, 6, 1769-1792; doi:10.3390*cancers6031769
Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011;28(3):753–765.
Jahn J.L., Giovannucci E.L., Stampfer M.J. The high prevalence of undiagnosed prostate cancer at autopsy: Implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen-era. Int. J. Cancer. 2015;137:2795–2802. doi: 10.1002*ijc.29408.
Je Y, Jeon JY, Giovannucci EL, et al. Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies. Int J Cancer. 2013; 133(8):1905–1913.
Jones S, et al. (2008) Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci USA 105:4283– 4288.
Krall JA, Ferenc R, Mercury OA, Pattabiraman DR, Brooks MW, Dougan M, Lambert AW, Bierie B, Ploegh HL, Dougan SK, Weinberg RA. The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy. Sci. Transl. Med. 10, eaan3464 (2018).
Lahart IM, Metsios GS, Nevill AM, et al. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54(5):635–654.
Lange MM, Rutten HJ, van de Velde CJ. One hundred years of curative surgery for rectal cancer: 1908-2008. Eur J Surg Oncol. 2009 May;35(5):456-63.
Legumes C.R. lemons and streptomycin: A short history of the clinical trial. CMAJ. 2009;180:23–24.
Levine EM & Robins EB. Differential temperature sensitivity of normal and cancer cells in culture. Journal of Cellular Physiology. 1970;76(3):373 – 379·
Li T, Wei S, Shi Y, et al. The dose-response effect of physical activity on cancer mortality: findings from 71 prospective cohort studies. Br J Sports Med. 2016;50(6):339–345.
Li Y, Zhou Y, Hong Y, He M, Wei S, Yang C, Zheng D and Liu F. The Efficacy of Different Chemotherapy Regimens for Advanced Biliary Tract Cancer: A Systematic Review and Network Meta-Analysis. Frontiers in Oncology. May 2019,Volume 9,Article 441.
Lutgendorf SK, Sood AK, Anderson B, et al. Social support, psychological distress, and natural killer cell activity in ovarian cancer. Journal of Clinical Oncology 2005;23(28):7105-7113.
Lutgendorf SK, DeGeest K, Dahmoush L, et al. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain, Behavior, and Immunity 2011;25(2):250-255.
Mackillop WJ, Stewart WE, Ginsburg AD, Stewart SS. Cancer patients’ perceptions of their disease and its treatment. Br J Cancer. 1988;58:355-358.
Maeda H and Khatami M. Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs, Clin Transl Med. 2018; 7: 11.
Mathews JD, Forsythe AV, Brady Z, et al. Cancer risk in 680000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 2013;346:f2360 doi: 10.1136*bmj.f2360 (Published 22 May 2013)
Mehrara E, Forssell-Aronsson E, Ahlman H, and Bernhardt P. Specific Growth Rate versus Doubling Time for Quantitative Characterization of Tumor Growth Rate. Cancer Res 2007; 67: (8). April 15, 2007
Meyerhardt JA, Heseltine D, Niedzwiecki D, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006;24(22):3535–3541.
Millimouno FM, Dong J, Yang L, Li J, and Li X. Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature. Cancer Prev Res; 2014; 7(11); 1081–107.
Moreno-Smith M, Lutgendorf SK, Sood AK. Impact of stress on cancer metastasis. Future Oncology 2010;6(12):1863-1881. doi: 10.2217*fon.10.142
Morgan G, Ward R & Barton M. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clin. Oncol. (R. Coll. Radiol.) 16, 549–560 (2004).
Na Z, Qiao X, Hao X, Fan L, Xiao Y, Shao Y, et. al. The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients. OncoTargets and Therapy 2018:11 4913–4944.
